Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06164067
Other study ID # 2011-KAEK-25 2022/04-52
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 15, 2022
Est. completion date August 15, 2022

Study information

Verified date December 2023
Source Sanliurfa Mehmet Akif Inan Education and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The main aim of the investigator study is the success of predictivity cervical consistency index (CCI), anterior uterocervical angle (aUCA) and posterior uterocervical angle (pUCA) in second trimester terminations.


Description:

This prospective clinical study includes 136 pregnant women with a diagnosis of in utero ex fetus who were hospitalized for medical termination in the gynecology service of Health Sciences University Bursa High Specialization Training and Research Hospital Gynecology and Obstetrics Clinic as a single center. The participants were divided into 2 groups as those whose treatment was completed in the first 24 hours (who were completely aborted and removed the fetal material and its attachments ) and those who aborted within 24-48 hours when additional cycles were needed. Furthermore who applied to additional treatment methods were recorded (cervical balloon, hysterotomy ) during these periods. In all pregnant women; characteristic features, abortion times, doses of misoprostol used, anterior- posterior uterocervical angle, cervical length, cervical consistency indexes and gestational weeks were saved.


Recruitment information / eligibility

Status Completed
Enrollment 136
Est. completion date August 15, 2022
Est. primary completion date August 15, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - women who had a termination indication in the second trimester and had abortion or abortion in our hospital - women who have had a miscarriage or abortion with a normal vaginal route or hysterotomy Exclusion Criteria: - multiple pregnancies - pregnant women with misoprostol-related allergies - scar pregnancies or heterotopic pregnancies - patients with a history of previous conization or cervical surgery, - patients with placental invasion anomaly

Study Design


Related Conditions & MeSH terms


Intervention

Other:
abortus within 24 hours or 24-48 hours
second trimester medical termination

Locations

Country Name City State
Turkey Nefise Nazli YENIGUL Bursa

Sponsors (1)

Lead Sponsor Collaborator
Sanliurfa Mehmet Akif Inan Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary success of predictivity cervical consistency index, anterior uterocervical angle and posterior uterocervical angle cervical consistency index (CCI), an ultrasound measurement that aims to estimate cervical softness by measuring the anteroposterior diameter of the uterine cervix before (AP) (millimeter) and at maximal compression (AP') with the vaginal ultrasound probe and calculating the ratio between the two measurements (AP'/AP × 100). Uterocervical angle (UCA) (degree):Transvaginal sonographic images showing technique of measurement of uterocervical angle. UCA was calculated as angle between two lines. The first line was drawn between internal (I) and external ostium (os) (E). The second line was drawn 3 cm parallel to the lower aspect of anterior inner uterine wall passing through the end of the first line at internal os. (in degrees) 6 months
Secondary compare the measured ultrasonographic values compare the measured ultrasonographic values with the success of predictivity cervical length.( millimeter) 6 months
See also
  Status Clinical Trial Phase
Terminated NCT04063904 - Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia Phase 4
Completed NCT03400358 - Uterocervical Angle in the Pregnancy Termination of Multiparous Women N/A
Recruiting NCT04501809 - Second Trimester Pregnancy Termination in Women With Previous Caesarean Sections N/A
Recruiting NCT03044093 - Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion Phase 4
Enrolling by invitation NCT06078501 - MisOpRostol Effect on Second Trimester Abortion Blood Loss Phase 3
Completed NCT04181541 - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester N/A
Completed NCT02033083 - Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation N/A
Recruiting NCT06123026 - Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion Phase 4
Terminated NCT03714880 - Cervical Preparation With Mifepristone Prior to Osmotic Dilators Phase 2
Completed NCT03407521 - Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion Phase 4